Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.
Researchers race to put hydroxychloroquine to the test in a large study.
A new AI-enabled disease management tool in China aims to improve the lives of millions of patients with heart failure.
Novartis announced the company’s financial results for the first quarter of 2020.
Researchers around the world are collaborating to provide solutions to immediate and future challenges.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.